Signature Therapeutics

Develops prodrug formulations that can prevent the misuse of prescription medications

placeSan Carlos, California, United States calendar_todayFounded 2004 groups5 employees language ensysce.com

Social engagement

Social engagement: 1.3K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Other / undisclosed2100%

Recent activity

11 May 2026
Event
Purple Therapeutics Summit Europe
19 Apr 2026
Milestone
regulatory
6 Apr 2026
Milestone
regulatory
Coming soon